FAPI PET/CT entheseal & synovial fibroblast activation predicts PsA in high risk PsO better than MUS @RheumNow #EULAR2024 https://t.co/uqmEvMg9WN

• https://twitter.com/drpnash/status/1801473801806319804/photo/1

more evidence in PsA - switch MOA rather than cycle within class failed first TNF @RheumNow #EULAR2024 https://t.co/hf2UB5MXEy

• https://twitter.com/drpnash/status/1801508656623526235/photo/1

opposing point of view especially in males at 3 years !@RheumNow #EULAR2024 https://t.co/CXxIScQbFD

• https://twitter.com/drpnash/status/1801509729711136816/photo/1

New #JAKi #disease #results #Baricitinib in #alopecia #areata esp 4mg/d #Upadacitinib in Crohn’s #Upa in #polyarticular #JIA & kid #PsA +RCT of UPA in #GCA Awaiting results of #SLE With #deucravicitinib & UPA #RCTs #EULAR2024 @eular_org @RheumNow

Do we give enough attention to pts mental health? 2 cohort 400+ RA tREACH & DEPAR 500+ PsA RA 20% depression 30% anxiety PsA 19% depression 22% anxiety 2 yrs no remission RA OR 2.5 depression OR 1.7 anxiety PsA OR 6.10 depression OR 4.67 anxiety @RheumNow #EULAR2024 POS0946 https://t.co/ok4HRNJqgY

• https://twitter.com/AurelieRheumo/status/1801624630626484634/photo/1

Cycle or swap 2? Post failure to a first TNFi in patients with PsA, there was no difference in cycle versus swap to IL17i for drug retention rate or disease activity. In male PsA patients a cycle strategy had a longer drug retention rate compared to a swap (IL-17i) strategy.… https://t.co/5BykvDwFWV https://t.co/GfcnIltV2A

• https://twitter.com/i/web/status/1801590870908518546
• https://twitter.com/synovialjoints/status/1801590870908518546/photo/1

What is better in #PsA #psoriatic #arthritis #TNFi or #apremilast #PDE4i #COREVITAS database study in #PsA YOU can guess the answer! 1st line advanced RxTNFi lasts longer - retention Vs PDE4i #EULAR2024 @RheumNow @eular_org POS0990 https://t.co/VmYG6Rj87c

• https://twitter.com/Janetbirdope/status/1801585969130356929/photo/1

Cycle or Swap? The swap strategy (SG) (i.e. from TNFi to IL17i) had higher retention rates compared to the change strategy (CG) choice in PsA patients who failed the first line of advanced treatment. The 5 years retention rate in SG was higher than in CG (57,8% vs 45,2%; p=0.1).… https://t.co/pH5rFI00vK https://t.co/XqTHO1tIr3

• https://twitter.com/i/web/status/1801585922292519240
• https://twitter.com/synovialjoints/status/1801585922292519240/photo/1
• https://twitter.com/synovialjoints/status/1801585922292519240/photo/1

Discovery in joint and skin disease - PsA Three different clusters #EULAR2024 @RheumNow https://t.co/Nj5HZOVqas

• https://twitter.com/bella_mehta/status/1801584877097336910/photo/1

The age old question in #inflammatory #arthritis Should you cycle within TNFi class or move on to another MOA in #PsA #psoriatic #arthritis Better retention to go to a IL17i vs another TNFi in observational study comparing the 2 POS0266 #EULAR2024 @RheumNow @eular_org https://t.co/CXcmYAG4m9

• https://twitter.com/Janetbirdope/status/1801582359914897665/photo/1
• https://twitter.com/Janetbirdope/status/1801582359914897665/photo/1